Camelid immunoglobulins and nanobody technology

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 178-183

  Muyldermans, S ^a   Baral, T N ^a   Retamozzo, V Cortez ^a   De Baetselier, P ^a   De Genst, E ^a   Kinne, J ^b   Leonhardt, H ^c,d   Magez, S ^a   Nguyen, V K ^a   Revets, H ^a   Rothbauer, U ^c,d   Stijlemans, B ^a   Tillib, S ^e   Wernery, U ^b   Wyns, L ^a   Hassanzadeh Ghassabeh, Gh ^a   Saerens, D ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b CENTRAL VETERINARY RESEARCH LABORATORY   (United Arab Emirates)

^c UNIVERSITY OF MUNICH   (Germany)

^d Munich Center for Integrated Protein Science   (Germany)

^e INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Dromedary; Heavy chain antibody; Llama; Single domain antibody

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN;

AMINO ACID SUBSTITUTION; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; ARTIODACTYLA; CAMEL; NANOTECHNOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; VDJ EXON;

ANIMALS; CAMELIDS, NEW WORLD; CAMELS; GENETIC ENGINEERING; IMMUNOGLOBULINS; NANOTECHNOLOGY;

CAMELIDAE; CAMELUS DROMEDARIUS; LAMA (MAMMAL);

EID: 60849118639     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.299     Document Type: Article

References (47)

1. Baral T.N., Magez S., Stijlemans B., Conrath K., Vanhollebeke B., Pays E., Muyldermans S., and De Baetselier P. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat. Med. 12 (2006) 580-584
2. Brüggemann M., Smith J.A., Osborn M., Corcos D., Zou X., Nguyen V.K., and Muyldermans S. Heavy chain only antibody expression and B-cell development in the mouse. Crit. Rev. Immunol. 26 (2006) 377-390
3. Conrath K.E., Lauwereys M., Wyns L., and Muyldermans S. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276 (2001) 7346-7350
4. Conrath K.E., Wernery U., Muyldermans S., and Nguyen V.K. Emergence and evolution of functional heavy-chain antibodies in Camelidae. Develop. Comp. Immunol. 27 (2003) 87-103
5. Cortez-Retamozo V., Backmann N., Senter P., Wernery U., De Baetselier P., Muyldermans S., and Revets H. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res. 64 (2004) 2853-2857
6. De Genst E., Handelberg F., Van Meirhaeghe A., Vinck S., Loris R., Wyns L., and Muyldermans S. Chemical basis for the affinity maturation of a camel single domain antibody. J. Biol. Chem. 279 (2004) 53593-53601
7. De Genst E., Saerens D., Muyldermans S., and Conrath K. Antibody repertoire development in camelids. Develop. Comp. Immunol. 30 (2006) 187-198
8. De Genst E., Silence K., Decanniere K., Conrath K., Loris R., Kinne J., Muyldermans S., and Wyns L. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 4586-4591
9. De Genst E., Silence K., Ghahroudi M.A., Decanniere K., Loris R., Kinne J., Wyns L., and Muyldermans S. Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires. J. Biol. Chem. 280 (2005) 14114-14121
10. Decanniere K., Muyldermans S., and Wyns L. Canonical antigen binding loop structures: more structures, more canonical classes?. J. Mol. Biol. 300 (2000) 83-91
11. Desmyter A., Spinelli S., Payan F., Lauwereys M., Wyns L., Muyldermans S., and Cambillau C. Three camelid VHH domains in complex with porcine pancreatic á-amylase: inhibition and versatility of binding topology. J. Biol. Chem. 277 (2002) 23645-23650
12. Desmyter A., Transue T.R., Arbabi Ghahroudi M., Dao-Thi M.-H., Poortmans F., Hamers R., Muyldermans S., and Wyns L. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat. Struct. Biol. 3 (1996) 803-811
13. Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., and Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 11 (2002) 500-515
14. Elkabetz Y., Argon Y., and Bar-Nun S. Cysteines in CH1 underlie retention of unassembled Ig heavy chains. J. Biol. Chem. 280 (2005) 14402-14412
15. Ferrari A., Rodriguez M.M., Power P., Weill F.S., De Simone E.A., Gutkind G., and Leoni J. Immunobiological role of llama heavy-chain antibodies against a bacterial β-lactamase. Vet. Immunol. Immunopathol. 117 (2007) 173-182
16. Frenken L., van der Linden R., Hermans P.W.J.J., Bos W., Ruuls R.C., de Geus B., and Verrips T. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J. Biotechnol. 78 (2000) 11-21
17. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Bajyana Songa E., Bendahman N., and Hamers R. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
18. Harmsen M.M., Ruuls R.C., Nijman I.J., Niewold T.A., Frenken L., and de Geus B. Llama heavy chain V-regions consist of at least four distinct subfamilies revealing novel sequence features. Molec. Immunol. 37 (2001) 579-590
19. Harmsen M.M., van Solt C.B., van Zijderveld-van Bemmel A.M., Niewold T.A., and van Zijderveld F.G. Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl. Microbiol. Biotechnol. 72 (2006) 544-551
20. Janssens R., Dekker S., Hendriks R.W., Panayotou G., van Remoortere A., San J.K., Grosveld F., and Drabek D. Generation of heavy-chain-only antibodies in mice. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 15130-15135
21. Lauwereys M., Ghahroudi M.A., Desmyter A., Kinne J., Hölzer W., De Genst E., Wyns L., and Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17 (1998) 3512-3520
22. Maass D.R., Sepulveda J., Pernthaner A., and Shoemaker C.B. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). J. Immunol. Methods 324 (2007) 13-25
23. Martensson I.L., Keenan R.A., and Licence S. The pre-B-cell receptor. Curr. Opin. Immunol. 19 (2007) 137-142
24. Muyldermans S., Atarhouch T., Saldanha J., Barbosa J.A.R.G., and Hamers R. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng. 7 (1994) 1129-1135
25. Muyldermans S., Cambillau C., and Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. TIBS 26 (2001) 230-235
26. Muyldermans S., and Lauwereys M. Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J. Mol. Recognit. 12 (1999) 1-10
27. Nguyen V.K., Desmyter A., and Muyldermans S. Functional heavy-chain antibodies in Camelidae. Adv. Immunol. 79 (2001) 261-296
28. Nguyen V.K., Hamers R., Wyns L., and Muyldermans S. Loss of splice consensus signal is responsible for the removal of the entire CH1 domain of the functional camel IgG2A heavy chain antibodies. Mol. Immunol. 36 (1999) 515-524
29. Nguyen V.K., Hamers R., Wyns L., and Muyldermans S. Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire. EMBO J. 19 (2000) 921-931
30. Nguyen V.K., Muyldermans S., and Hamers R. The specific variable domain of camel heavy-chain antibodies is encoded in the germline. J. Mol. Biol. 257 (1998) 413-418
31. Nguyen V.K., Zou X., Lauwereys M., Brys L., Brüggemann M., and Muyldermans S. Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells. Immunology 109 (2003) 93-101
32. Padlan E.A. Anatomy of the antibody molecule. Molec. Immunol. 31 (1994) 169-217
33. Rothbauer U., Zolghadr K., Muyldermans S., Schepers A., Cardoso C.M., and Leonhardt H. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell. Proteomics 7 (2008) 282-289
34. Rothbauer U., Zolghadr K., Tillib S., Nowak D., Schermelleh L., Gahl A., Backmann N., Conrath K., Muyldermans S., Cardoso C.M., and Leonhardt H. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 3 (2006) 887-889
35. Saerens D., Kinne J., Bosmans E., Wernery U., Muyldermans S., and Conrath K. Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J. Biol. Chem. 279 (2004) 51965-51972
36. Saerens D., Pellis M., Loris R., Pardon E., Dumoulin M., Matagne A., Wyns L., Muyldermans S., and Conrath K. Identification of a universal framework to graft non-canonical antigen binding loops of camel single domain antibodies. J. Mol. Biol. 352 (2005) 597-607
37. Stijlemans B., Conrath K., Cortez-Retamozo V., Van Xong H., Wyns L., Senter P.D., Revets H., De Baetselier P., Muyldermans S., and Magez S. Efficient targeting of conserved cryptic epitopes of infectious agents by single-domain antibodies: African trypanosomes as paradigm. J. Biol. Chem. 279 (2004) 1256-1261
38. Tanha J., Xu P., Chen Z., Ni F., Kaplan H., Narang S.A., and MacKenzie R. Optimal design features of camelized human single domain antibody libraries. J. Biol. Chem. 276 (2001) 24774-24780
39. Transue T.R., De Genst E., Ghahroudi M.A., Wyns L., and Muyldermans S. Camel single domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins: Struct. Funct. Genetics 32 (1998) 515-522
40. van der Linden R.H.J., de Geus B., Frenken L., Peters H., and Verrips T. Improved production and function of llama heavy chain antibody fragments by molecular evolution. J. Biotechnol. 80 (2000) 261-270
41. Verheesen P., Roussis A., de Haard H.J., Groot A.J., Stam J.C., den Dunnen J.T., Frants R.R., Verkleij A.J., Verrips T.C., and van der Maarel S.M. Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim. Biophys. Acta 1764 (2006) 1307-1319
42. Vu K.B., Ghahroudi M.A., Wyns L., and Muyldermans S. Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol. Immunol. 34 (1997) 1121-1131
43. Woolven B.P., Frenken L., van der Logt P., and Nicholls P.J. The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation. Immunogenetics 50 (1999) 98-101
44. Wu T.T., Johnson G., and Kabat E.A. Length distribution of CDR H3 in antibodies. Proteins: Struct. Funct. Genetics 16 (1993) 1-7
45. Yau K.Y.F., Groves M.A.T., Li S., Sheedy C., Lee H., Tnaha J., MacKenzie C.R., Jermutus L., and Hall J.C. Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. J. Immunol. Methods 281 (2003) 161-175
46. Zhao Y., Kacskovics I., Pan Q., Liberles D.A., Geli J., Davis S.K., Rabbani H., and Hammarstrom L. Artiodactyl IgD: the missing link. J. Immunol. 169 (2002) 4408-4416
47. Zou X., Smith J.A., Nguyen V.K., Ren L., Luyten K., Muyldermans S., and Brüggemann M. Expression of a dromedary heavy-chain only antibody and B cell development in the mouse. J. Immunol. 175 (2005) 3769-3779